Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Non-Current Assets (2017 - 2025)

Inspire Medical Systems' Non-Current Assets history spans 9 years, with the latest figure at $323.7 million for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 82.27% year-over-year to $323.7 million; the TTM value through Dec 2025 reached $933.0 million, up 49.02%, while the annual FY2025 figure was $323.7 million, 82.27% up from the prior year.
  • Non-Current Assets for Q4 2025 was $323.7 million at Inspire Medical Systems, up from $221.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $323.7 million in Q4 2025 and bottomed at $12.6 million in Q1 2021.
  • The 5-year median for Non-Current Assets is $64.0 million (2023), against an average of $100.8 million.
  • The largest annual shift saw Non-Current Assets soared 440.81% in 2021 before it rose 3.53% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $26.5 million in 2021, then surged by 31.25% to $34.8 million in 2022, then soared by 138.41% to $83.1 million in 2023, then soared by 113.76% to $177.6 million in 2024, then skyrocketed by 82.27% to $323.7 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Non-Current Assets are $323.7 million (Q4 2025), $221.2 million (Q3 2025), and $229.0 million (Q2 2025).